Skip to main content

UBS Group AG

Position in ACHV — Achieve Life Sciences, Inc.

CIK 1610520 ZURICH, V8

Position in ACHV

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,043,916
+$1,084,684 QoQ
Shares Held
313,004
-4.1% QoQ
Ownership
0.304%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 111 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACHV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. ACHV ranks #213 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ACHV

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,043,916 313,004
2026-03-31 $959,232 326,270
2025-12-31 $1,417,586 285,229
2025-09-30 $249,296 79,142
2025-06-30 $191,905 84,914
2025-03-31 $176,465 66,092
2024-12-31 $184,243 52,342
2024-09-30 $76,967 16,238
2024-06-30 $49,114 10,450
2024-03-31 $9 2
2023-12-31 $8 2
2023-09-30 $5,413 1,259
2023-06-30 $861 166
2023-03-31 $4,936 726
2022-06-30 $5,255 1,077
2021-12-31 $622 80
2021-09-30 $680 80
2021-06-30 $5,288 589
2020-12-31 $41,018 5,064
2020-09-30 $16,957 2,026
2020-06-30 $36,777 91,946
2020-03-31 $25,935 78,595